Application 212428
- Type
- ANDA
- Sponsor
- GLASSHOUSE PHARMACEUTICALS LTD CANADA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | OXCARBAZEPINE | OXCARBAZEPINE | SUSPENSION;ORAL | 300MG/5ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 71428-007 | Oxcarbazepine | oxcarbazepine | Glasshouse Pharmaceuticals Limited Canada | ANDA | Current |
| 71428-007 | Oxcarbazepine | oxcarbazepine | Glasshouse Pharmaceuticals Limited Canada | ANDA | Current |
| 71428-007 | Oxcarbazepine | oxcarbazepine | Glasshouse Pharmaceuticals Limited Canada | ANDA | Current |